Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Annals of Translational Medicine|August 23, 2021
Clinical comparison of tenosynovial giant cell tumors, synovial chondromatosis, and synovial sarcoma: analysis and report of 53 casesWei Wang, Man-Mei Long, Cheng-Jiang Wei, et al.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|April 19, 2013
[Studies on spray of niclosamide ethanolamine salt II observation on prevention of Schistosoma japonicum infection in bovine]Jian-Rong Dai, Yun-Tian Xing, Hong-Jun Li, et al.
Frontiers in Cell and Developmental Biology|November 9, 2020
Protein Tyrosine Phosphatase Receptor S Acts as a Metastatic Suppressor in Malignant Peripheral Nerve Sheath Tumor via Profilin 1-Induced Epithelial-Mesenchymal TransitionJie-Yi Ren, Yi-Hui Gu, Xi-Wei Cui, et al.
Plos One|June 16, 2016
4-Phenylbutyric Acid Induces Protection against Pulmonary Arterial Hypertension in RatsYun Wu, Dilare Adi, Mei Long, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 6, 2022
Light-Triggered Efficient Sequential Drug Delivery of Biomimetic Nanosystem for Multimodal Chemo-, Antiangiogenic, and Anti-MDSC Therapy in MelanomaXing Lai, Xue-Liang Liu, Hong Pan, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 5, 2011
[Liver histological changes in chronic hepatitis B patients with elevated ALT less than 2 x ULN]Jian-Chun Xian, Hong-Tao Xu, Yi-Lin He, et al.
Frontiers in Pharmacology|November 15, 2021
Saikosaponin A, a Triterpene Saponin, Suppresses Angiogenesis and Tumor Growth by Blocking VEGFR2-Mediated Signaling PathwayPan Zhang, Xing Lai, Mao-Hua Zhu, et al.
Marine Drugs|May 15, 2014
Marine compound catunaregin inhibits angiogenesis through the modulation of phosphorylation of akt and eNOS in vivo and in vitroJun-Xiu Liu, Min-Qi Luo, Meng Xia, et al.
Plos One|February 25, 2021
Selection of internal references for RT-qPCR assays in Neurofibromatosis type 1 (NF1) related Schwann cell linesYi-Hui Gu, Xi-Wei Cui, Jie-Yi Ren, et al.
Nature Medicine|March 3, 2026
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trialPing Wan, Siyuan Tang, Dongni Lin, et al.
Pageof 12